Welcome to our dedicated page for Sotera Health Co news (Ticker: SHC), a resource for investors and traders seeking the latest updates and insights on Sotera Health Co stock.
Sotera Health Company (NASDAQ: SHC) is described as a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry. Through its Sterigenics, Nordion and Nelson Labs businesses, the company focuses on sterilization, analytical testing and related services that support the safety of medical, pharmaceutical and food products.
The SHC news feed on Stock Titan highlights company announcements that matter to investors and observers of the healthcare services and testing laboratories space. These include quarterly and year-to-date financial results, updates on revenue trends and segment performance for Sterigenics, Nordion and Nelson Labs, as well as information on leverage, credit facilities and other balance sheet items described in press releases and Form 8-K filings.
Users can also follow news about secondary offerings of common stock by selling stockholders, as disclosed in company press releases and related 8-K filings. These items explain when affiliates of investment firms have sold blocks of SHC shares and clarify that Sotera Health did not receive proceeds from those transactions.
Regulatory and legal developments are another important category of news for Sotera Health. Public disclosures describe litigation and settlements related to ethylene oxide emissions at certain Sterigenics facilities, along with broader risk discussions around EO, Co-60 supply, regulatory changes and international operations. Conference participation, earnings release dates and management presentations at healthcare investor events are also covered in the company’s news flow.
By reviewing this news stream, readers can see how Sotera Health communicates its financial performance, capital markets activity, legal developments and strategic positioning in sterilization and lab testing services over time.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
CLEVELAND, April 18, 2023 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC) plans to release its financial results for the first quarter ended March 31, 2023, before market opens on May 3, 2023. Following the release, management will host a conference call at 9:00 a.m. Eastern Time to discuss operational highlights.
Participants can join the call by dialing 1-866-777-2509 from the U.S. or 1-412-317-5413 from other locations. A live webcast and materials will be available via the Company's Investor Relations section. A replay will be available later on May 3.
Sotera Health Company (Nasdaq: SHC) announced an amendment to its First Lien Credit Agreement, increasing its revolving loan commitments by $76.3 million. This boosts the total commitments under the Revolving Credit Facility from $347.5 million to $423.8 million and enhances lender commitments for letters of credit from about $196 million to $361 million. The amendment replaces the LIBOR interest rate option with Term SOFR or Daily SOFR rates. No balance is currently outstanding under this facility, and the company does not anticipate needing to borrow in the near term, maintaining a maturity date of June 13, 2026.
Sotera Health Company (SHC) reported a 4.3% increase in Q4 2022 net revenues to $252 million, despite a net loss of $320 million, significantly influenced by a $408 million legal reserve. Adjusted EBITDA rose 4% to $130 million, with Adjusted EPS improving to $0.25. For FY 2022, net revenues grew 7.8% to $1,004 million, while net loss was $234 million. The outlook for FY 2023 includes net revenue growth of 5% to 9%, with Adjusted EPS expected to decline by 10% to 19% due to rising interest expenses. The company closed a $500 million Term Loan B to address the EO settlement and enhance liquidity.